Cargando…
Changes in Anti-SARS-CoV-2 IgG Subclasses over Time and in Association with Disease Severity
IgG is the most prominent marker of post-COVID-19 immunity. Not only does this subtype mark the late stages of infection, but it also stays in the body for a timespan of at least 6 months. However, different IgG subclasses have different properties, and their roles in specific anti-COVID-19 response...
Autores principales: | Korobova, Zoia R., Zueva, Elena V., Arsentieva, Natalia A., Batsunov, Oleg K., Liubimova, Natalia E., Khamitova, Irina V., Kuznetsova, Raisa N., Rubinstein, Artem A., Savin, Tikhon V., Stanevich, Oksana V., Kulikov, Alexandr N., Pevtsov, Dmitry E., Totolian, Areg A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9143443/ https://www.ncbi.nlm.nih.gov/pubmed/35632683 http://dx.doi.org/10.3390/v14050941 |
Ejemplares similares
-
Heterogenous CD8+ T Cell Maturation and ‘Polarization’ in Acute and Convalescent COVID-19 Patients
por: Kudryavtsev, Igor V., et al.
Publicado: (2022) -
Cytokine Profiling in Different SARS-CoV-2 Genetic Variants
por: Korobova, Zoia R., et al.
Publicado: (2022) -
Alterations in B Cell and Follicular T-Helper Cell Subsets in Patients with Acute COVID-19 and COVID-19 Convalescents
por: Kudryavtsev, Igor V., et al.
Publicado: (2021) -
A Comparative Study of the Plasma Chemokine Profile in COVID-19 Patients Infected with Different SARS-CoV-2 Variants
por: Korobova, Zoia R., et al.
Publicado: (2022) -
Macrophage-Derived Chemokine MDC/CCL22: An Ambiguous Finding in COVID-19
por: Korobova, Zoia R., et al.
Publicado: (2023)